Major Trauma Clinical Trial
Official title:
Pragmatic Prospective, Multicentre Feasibility Non-randomised Controlled Trial on Enhanced Rehabilitation for Poly & Lower Extremity Trauma (PROPERLY Trial)
The goal of this study is to assess the feasibility of recruitment, and barriers to delivery of an enhanced rehabilitation service, in patients surviving major trauma. The main questions it aims to answer are: are the investigators able to recruit patients to a research study are the investigators able to retain patients in the research study are the investigators able to identify appropriate primary outcome measures are the investigators able to identify barriers to future large-scale definitive trial or service delivery Participants will would be offered at least two sessions of the Enhanced Rehabilitation Programme (ERP), each lasting 60-120 minutes per week, delivered in the Manchester Institute of Health and Performance (MIHP). Participants not willing to travel to the MIHP, or declining to engage in the ERP, will be asked to join the Standard Care (SC) group. This group will provide questionnaire data and clinical outcome measure collection with their usual place of therapy. Researchers will compare the ERP group and the SC groups to assess any additional benefits to the ERP.
The investigators will aim to recruit 25 participants for the ERP and 25 participants in SC (50 in total) who will go through a series of quantitative functional assessments and patient reported outcome measures, at baseline (at the beginning of the programme), middle (3 months), on discharge from the programme (usually 6 months). If patients are discharged earlier, assessments will be performed at the discharge visit. Assessments using PROMS will be conducted at baseline (at the beginning of the programme), middle (3 months), on discharge from the programme (usually 6 months), and 12 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02509390 -
Hyperfibrinogenemia After Major Trauma
|
N/A | |
| Recruiting |
NCT04970433 -
The Effects of Acupuncture for Major Trauma
|
N/A | |
| Recruiting |
NCT04588311 -
ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients
|
Phase 3 | |
| Active, not recruiting |
NCT04144803 -
Brain Oxygenation During Prehospital Anesthesia: an Observational Study
|
||
| Completed |
NCT03259776 -
Experiences of Visitors to a Regional Major Trauma Intensive Care Unit
|
||
| Recruiting |
NCT05449522 -
Vitamin D for Critically Traumatic Patients
|
N/A | |
| Not yet recruiting |
NCT06103292 -
Calcium Levels in Major Trauma
|
||
| Recruiting |
NCT02877342 -
Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India
|
N/A | |
| Terminated |
NCT01545635 -
RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
|
Phase 3 | |
| Completed |
NCT03986736 -
Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
|
||
| Completed |
NCT03005509 -
Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India
|
N/A | |
| Completed |
NCT02165137 -
Management of Major Trauma Patients at Aarau Trauma Center - Evaluation of Processes and Patient Outcome
|
||
| Active, not recruiting |
NCT06376318 -
Shock and Acute Conditions OutcOmes Platform
|
||
| Recruiting |
NCT05996068 -
Arterial Line in Trauma Resuscitation
|
N/A | |
| Completed |
NCT06007807 -
Severe Trauma Registry in Tarragona
|
||
| Completed |
NCT03354559 -
Trauma Associated Bleeding: Effectiveness of an Early Coagulation Support Protocol
|
N/A | |
| Completed |
NCT00588796 -
Study of Fibrinogen Metabolism During Severe Trauma and Burns
|
N/A | |
| Completed |
NCT04216459 -
Effect of Anti-inflammatory and Anti-microbial Co-supplementations in Traumatic ICU Patients at High Risk of Sepsis
|
N/A | |
| Terminated |
NCT04551157 -
Impact of Psychoeducational Video on Adjustment to Open Fracture.
|
N/A | |
| Completed |
NCT02000674 -
Succinylcholine vs Rocuronium for Prehospital Emergency Intubation
|
Phase 3 |